Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence ; volume:31 ; number:3 ; day:4 ; month:3 ; year:2023 ; pages:1-11 ; date:3.2023
Supportive care in cancer ; 31, Heft 3 (4.3.2023), 1-11, 3.2023
- Urheber
-
Cahir, Caitriona
Bennett, Kathleen
Dombrowski, Stephan U.
Kelly, Catherine M.
Wells, Mary
Watson, Eila
Sharp, Linda
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-07658-x
- URN
-
urn:nbn:de:101:1-2408070926589.165010289184
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cahir, Caitriona
- Bennett, Kathleen
- Dombrowski, Stephan U.
- Kelly, Catherine M.
- Wells, Mary
- Watson, Eila
- Sharp, Linda
- SpringerLink (Online service)
Ähnliche Objekte (12)
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients
Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
Prevalence and Modifiable Determinants of Non-Adherence in Adult Kidney Transplant Recipients in a German Sample
Status of adjuvant endocrine therapy for breast cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Correction to: Impacts of medication non‑adherence to major modifiable stroke‑related diseases on stroke prevention and mortality: a meta‑analysis
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Modifiable Factors Associated with Non-adherence to Antihypertensive or Antihyperlipidemic Drugs Are Dissimilar: a Multicenter Study Among Patients with Diabetes in Indonesia
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients
Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
Prevalence and Modifiable Determinants of Non-Adherence in Adult Kidney Transplant Recipients in a German Sample
Status of adjuvant endocrine therapy for breast cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Correction to: Impacts of medication non‑adherence to major modifiable stroke‑related diseases on stroke prevention and mortality: a meta‑analysis
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Modifiable Factors Associated with Non-adherence to Antihypertensive or Antihyperlipidemic Drugs Are Dissimilar: a Multicenter Study Among Patients with Diabetes in Indonesia
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients
Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis
Prevalence and Modifiable Determinants of Non-Adherence in Adult Kidney Transplant Recipients in a German Sample
Status of adjuvant endocrine therapy for breast cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Correction to: Impacts of medication non‑adherence to major modifiable stroke‑related diseases on stroke prevention and mortality: a meta‑analysis
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer